Table III.
Change in Office Blood Pressure
| Reference, Year | N (I; C) | Baseline Office Recording of Blood Pressure, SBP/DBP | 1 Mo | 3 Mo | 6 Mo | 9 Mo | 12 Mo | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | C | I | C | I | C | I | C | I | C | I | C | ||
| Randomized control trials | |||||||||||||
| Ukena (2011) | 37; 9 | 172/94 | 166/90 | NR | NR | −31/−9 | 0/−1 | NR | NR | NR | NR | NR | NR |
| Symplicity HTN‐2 (2010) | 52; 54 | 178/97 | 178/98 | NR | NR | NR | NR | −32/−12 | +1/0 | NR | NR | −28.1/−9.7 | NR |
| Case control studies | |||||||||||||
| Mahfoud (2012) | 88; 12 | 174/95 | 184/97 | NR | NR | −22.7/−7.7 | −7.2/−4.1 | −26.6/−9.7 | −4.4/−3.0 | NR | NR | NR | NR |
| Brandt (2012) | 46; 18 | 180.7/95.8 | 184.5/98.2 | −22.5/−7.2 | −2.9/−0.2 | NR | NR | −27.8/−8.8 | −2.7/+1.6 | NR | NR | NR | NR |
| Mahfoud (2011) | 37; 13 | 178/96 | 177/96 | −28/−10 | ‐8/−4 | −32/−12 | −5/−3 | NR | NR | NR | NR | NR | NR |
| Krum (2009) | 45; 5 | 177/101 | 173/98 | −14/−10 | +3/−2 | −21/−10 | +2/+3 | −22/−11 | +14/+9 | −24/−11 | +26/+17 | −27/−17 | NR |
| Case series | |||||||||||||
| Hering (2012) | 15 | 174/91 | −34/−14 | −25/−11 | −32/−15 | NR | −33/−19 | ||||||
| Himmel (2012) | 14 | 170/94 | −16/−6 | −23/−8 | NR | NR | NR | ||||||
| Mabin (2012) | 11 | 180/109 | −30/−15 | −36/−17 | NR | NR | NR | ||||||
| Mylotte (2012) | 33 | 181.1/100.8 | NR | NR | −30.3/−14.6 | NR | NR | ||||||
| Verloop (2012) | 22 | 197/106 | NR | NR | −24/−13 | NR | NR | ||||||
| Symplicity HTN‐1 (2011) | 153 | 176/98 | −20/−10 | −24/−11 | −25/−11 | NR | −23/−11 | ||||||
| Voskuil (2011) | 11 | 203/109 | −25/−12 | NR | NR | NR | NR | ||||||
| Witkowsky (2011) | 12 | 173/106 12 | NR | −22 | −34/−13 | NR | NR | ||||||
Abbreviations: C, control group; DBP, diastolic blood pressure; I, intervention group; NR, not reported; SBP, systolic blood pressure.